Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
My Take: 4 Strong Growth Stocks to Buy This Week
07:34am, Friday, 23'rd Sep 2022
Quality and resiliency shine through when trouble starts setting in.
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
01:14pm, Thursday, 22'nd Sep 2022
Merck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris over an ingredient used in diabetes meds. The post Merck Stock Surges After Winning Patent Battle V
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?
10:32am, Thursday, 22'nd Sep 2022
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Merck: A Gem In A Period Of Economic And Geopolitical Uncertainties
02:59pm, Wednesday, 21'st Sep 2022
Merck's operating income was $5,293 million in Q2 2022, up 37.5% year-over-year. Merck's key medicines have received regulatory approvals from the US and Europe, thereby increasing the number of indic
Merck (MRK) Resumes HIV Studies on Islatravir With Lower Dose
01:33pm, Wednesday, 21'st Sep 2022
Merck's (MRK) new phase III studies are set to evaluate a once-daily oral combination of doravirine and a lower dose of islatravir
3 Best Dow Jones Stocks of 2022 So Far: Are They Buys Now?
05:52am, Wednesday, 21'st Sep 2022
It hasn't taken huge returns to rank among the top three of the Dow this year.
3 Stocks That Could Rocket on Biden's Cancer Moonshot
04:18pm, Tuesday, 20'th Sep 2022
The idea that anyone could have a problem with Joe Biden's cancer moonshot is unimaginable. After all, who hasn't had a friend or relative affected by cancer?
The 7 Best Biotech Stocks to Buy
01:45pm, Tuesday, 20'th Sep 2022
I've written before about how biotech is the biggest technology trend of our kids' generation. Naturally, that means many people are looking for the best biotech stocks to buy.
Merck launches new Phase 3 trial of once-daily HIV treatment, to discontinue trial of once-monthly dose
07:00am, Tuesday, 20'th Sep 2022
Merck MRK, -1.23% said Tuesday it is launching a new Phase 3 trial of once-daily islatravir for the treatment of people with HIV-1 infection. "These new Phase 3 studies will evaluate a once-daily oral
A potential gas shortages poses no major risk to our 2022 outlook, Merck KGaA CFO says
03:17am, Tuesday, 20'th Sep 2022
Marcus Kuhnert, CFO of science and technology company Merck KGaA, discusses the firm's third-quarter outlook and the implications of Europe's energy crisis on the business.
Merck's (MRK) Pneumococcal Jab Gets CHMP Endorsement for Kids
01:32pm, Monday, 19'th Sep 2022
The EMA's CHMP recommends approving Merck's (MRK) pneumococcal 15-valent conjugate vaccine for expanded use in infants and children. The vaccine received similar approval from the FDA in June 2022.
Lido Advisors' Sanchez breaks down the bull case for Merck and Unilever
02:50pm, Friday, 16'th Sep 2022
Gina Sanchez, Lido Advisors chief market strategist, joins 'The Exchange' to discuss Sanchez's volatility survival guide and which stocks to consider.
7 Undervalued Stock Picks to Beat the September Market Slump
01:05pm, Friday, 16'th Sep 2022
Although the tail end of the third quarter brought some unwanted volatility to the market, forward-thinking investors might want to use this time to strategize undervalued stock picks. One of the prim
Fund Tops Market With Higher Income, Low Volatility Strategy
07:00am, Friday, 16'th Sep 2022
Are you spooked because the S&P 500 is off 16.26% going into Thursday? If you are, then check out Hartford Equity Income Fund.
Why This Monster Stock's Recent Blunders Might Not Matter
10:37am, Thursday, 15'th Sep 2022
Strong sales of its top blockbuster overcome some weaker pipeline results.
